LH receptor agonists (Serono)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLH receptor agonists (Serono)
Drug Alias Nameluteinizing hormone receptor agonist (Serono)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLuteinizing hormone/Choriogonadotropin receptor agonists
TargetsLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsTesticular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono Sa
Active IndicationsN/A
Inactive IndicationsTesticular Diseases

Other Information

ATC CodeN/A
Related LinksN/A